The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Latent Tuberculosis Infection (LTBI) Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Latent Tuberculosis Infection (LTBI) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Latent Tuberculosis Infection (LTBI) Testing market size is estimated to be worth US$ 1436.4 million in 2021 and is forecast to a readjusted size of USD 2043.9 million by 2028 with a CAGR of 5.2% during review period. Hospitals and Clinics accounting for % of the Latent Tuberculosis Infection (LTBI) Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tuberculin Skin Test (TST) segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Latent Tuberculosis Infection (LTBI) Testing include Qiagen, Sanofi, Oxford Immunotec, Thermo Fisher Scientific, and Par Sterile, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Latent Tuberculosis Infection (LTBI) Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Market segment by Application, can be divided into
Hospitals and Clinics
Diagnostic Laboratories
Others
Market segment by players, this report covers
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Latent Tuberculosis Infection (LTBI) Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Latent Tuberculosis Infection (LTBI) Testing, with revenue, gross margin and global market share of Latent Tuberculosis Infection (LTBI) Testing from 2019 to 2022.
Chapter 3, the Latent Tuberculosis Infection (LTBI) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Latent Tuberculosis Infection (LTBI) Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Latent Tuberculosis Infection (LTBI) Testing research findings and conclusion, appendix and data source.
Geographical Area
Global
The Latent Tuberculosis Infection (LTBI) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Latent Tuberculosis Infection (LTBI) Testing market size is estimated to be worth US$ 1436.4 million in 2021 and is forecast to a readjusted size of USD 2043.9 million by 2028 with a CAGR of 5.2% during review period. Hospitals and Clinics accounting for % of the Latent Tuberculosis Infection (LTBI) Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tuberculin Skin Test (TST) segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Latent Tuberculosis Infection (LTBI) Testing include Qiagen, Sanofi, Oxford Immunotec, Thermo Fisher Scientific, and Par Sterile, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Latent Tuberculosis Infection (LTBI) Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Market segment by Application, can be divided into
Hospitals and Clinics
Diagnostic Laboratories
Others
Market segment by players, this report covers
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Latent Tuberculosis Infection (LTBI) Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Latent Tuberculosis Infection (LTBI) Testing, with revenue, gross margin and global market share of Latent Tuberculosis Infection (LTBI) Testing from 2019 to 2022.
Chapter 3, the Latent Tuberculosis Infection (LTBI) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Latent Tuberculosis Infection (LTBI) Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Latent Tuberculosis Infection (LTBI) Testing research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Latent Tuberculosis Infection (LTBI) Testing
1.2 Classification of Latent Tuberculosis Infection (LTBI) Testing by Type
1.2.1 Overview: Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type in 2021
1.2.3 Tuberculin Skin Test (TST)
1.2.4 Interferon Gamma Released Assay (IGRA)
1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market by Application
1.3.1 Overview: Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Global Latent Tuberculosis Infection (LTBI) Testing Market Size & Forecast
1.5 Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast by Region
1.5.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Region, (2017-2022)
1.5.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2017-2028)
1.5.6 South America Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Latent Tuberculosis Infection (LTBI) Testing Market Drivers
1.6.2 Latent Tuberculosis Infection (LTBI) Testing Market Restraints
1.6.3 Latent Tuberculosis Infection (LTBI) Testing Trends Analysis
2 Company Profiles
2.1 Qiagen
2.1.1 Qiagen Details
2.1.2 Qiagen Major Business
2.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.1.4 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Qiagen Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.2.4 Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Oxford Immunotec
2.3.1 Oxford Immunotec Details
2.3.2 Oxford Immunotec Major Business
2.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.3.4 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Oxford Immunotec Recent Developments and Future Plans
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.4.4 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.5 Par Sterile
2.5.1 Par Sterile Details
2.5.2 Par Sterile Major Business
2.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.5.4 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Par Sterile Recent Developments and Future Plans
2.6 Bio-Rad Laboratories
2.6.1 Bio-Rad Laboratories Details
2.6.2 Bio-Rad Laboratories Major Business
2.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
2.6.4 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Bio-Rad Laboratories Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Latent Tuberculosis Infection (LTBI) Testing Players Market Share in 2021
3.2.2 Top 10 Latent Tuberculosis Infection (LTBI) Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Latent Tuberculosis Infection (LTBI) Testing Players Head Office, Products and Services Provided
3.4 Latent Tuberculosis Infection (LTBI) Testing Mergers & Acquisitions
3.5 Latent Tuberculosis Infection (LTBI) Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2017-2022)
5.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2017-2028)
6.2 North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2017-2028)
6.3 North America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
6.3.1 North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Country (2017-2028)
6.3.2 United States Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2017-2028)
7.2 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2017-2028)
7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
7.3.1 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Country (2017-2028)
7.3.2 Germany Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
7.3.3 France Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Market Size by Region
8.3.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Region (2017-2028)
8.3.2 China Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
8.3.5 India Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2017-2028)
9.2 South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2017-2028)
9.3 South America Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
9.3.1 South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Country (2017-2028)
9.3.2 Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Country
10.3.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue by Country (2017-2028)
10.3.2 Turkey Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Latent Tuberculosis Infection (LTBI) Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Region (2023-2028)
Table 6. Qiagen Corporate Information, Head Office, and Major Competitors
Table 7. Qiagen Major Business
Table 8. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 9. Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Sanofi Corporate Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 13. Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Oxford Immunotec Corporate Information, Head Office, and Major Competitors
Table 15. Oxford Immunotec Major Business
Table 16. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 17. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 19. Thermo Fisher Scientific Major Business
Table 20. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 21. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Par Sterile Corporate Information, Head Office, and Major Competitors
Table 23. Par Sterile Major Business
Table 24. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 25. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Bio-Rad Laboratories Major Business
Table 28. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 29. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 31. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 32. Breakdown of Latent Tuberculosis Infection (LTBI) Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Latent Tuberculosis Infection (LTBI) Testing Players Head Office, Products and Services Provided
Table 34. Latent Tuberculosis Infection (LTBI) Testing Mergers & Acquisitions in the Past Five Years
Table 35. Latent Tuberculosis Infection (LTBI) Testing New Entrants and Expansion Plans
Table 36. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Type (2017-2022)
Table 37. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type (2017-2022)
Table 38. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast by Type (2023-2028)
Table 39. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2017-2022)
Table 40. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast by Application (2023-2028)
Table 41. North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2017-2022) & (USD Million)
Table 42. North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2023-2028) & (USD Million)
Table 43. North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2017-2022) & (USD Million)
Table 44. North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2023-2028) & (USD Million)
Table 45. North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Country (2017-2022) & (USD Million)
Table 46. North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Country (2023-2028) & (USD Million)
Table 47. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2017-2022) & (USD Million)
Table 48. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2023-2028) & (USD Million)
Table 49. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2017-2022) & (USD Million)
Table 50. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2023-2028) & (USD Million)
Table 51. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Country (2017-2022) & (USD Million)
Table 52. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Country (2023-2028) & (USD Million)
Table 53. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2017-2022) & (USD Million)
Table 54. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2023-2028) & (USD Million)
Table 55. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2017-2022) & (USD Million)
Table 56. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2023-2028) & (USD Million)
Table 57. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Region (2017-2022) & (USD Million)
Table 58. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Region (2023-2028) & (USD Million)
Table 59. South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2017-2022) & (USD Million)
Table 60. South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2023-2028) & (USD Million)
Table 61. South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2017-2022) & (USD Million)
Table 62. South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2023-2028) & (USD Million)
Table 63. South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Country (2017-2022) & (USD Million)
Table 64. South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Country (2023-2028) & (USD Million)
Table 65. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2017-2022) & (USD Million)
Table 66. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue by Type (2023-2028) & (USD Million)
Table 67. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2017-2022) & (USD Million)
Table 68. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2023-2028) & (USD Million)
Table 69. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue by Country (2017-2022) & (USD Million)
Table 70. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Latent Tuberculosis Infection (LTBI) Testing Picture
Figure 2. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type in 2021
Figure 3. Tuberculin Skin Test (TST)
Figure 4. Interferon Gamma Released Assay (IGRA)
Figure 5. Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application in 2021
Figure 6. Hospitals and Clinics Picture
Figure 7. Diagnostic Laboratories Picture
Figure 8. Others Picture
Figure 9. Global Latent Tuberculosis Infection (LTBI) Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Region (2017-2028)
Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Region in 2021
Figure 13. North America Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Latent Tuberculosis Infection (LTBI) Testing Market Drivers
Figure 19. Latent Tuberculosis Infection (LTBI) Testing Market Restraints
Figure 20. Latent Tuberculosis Infection (LTBI) Testing Market Trends
Figure 21. Qiagen Recent Developments and Future Plans
Figure 22. Sanofi Recent Developments and Future Plans
Figure 23. Oxford Immunotec Recent Developments and Future Plans
Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 25. Par Sterile Recent Developments and Future Plans
Figure 26. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 27. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players in 2021
Figure 28. Latent Tuberculosis Infection (LTBI) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 29. Global Top 3 Players Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share in 2021
Figure 30. Global Top 10 Players Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share in 2021
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 32. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type in 2021
Figure 33. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Type (2023-2028)
Figure 34. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Application in 2021
Figure 35. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Application (2023-2028)
Figure 36. North America Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Type (2017-2028)
Figure 37. North America Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Application (2017-2028)
Figure 38. North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Country (2017-2028)
Figure 39. United States Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Type (2017-2028)
Figure 43. Europe Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Application (2017-2028)
Figure 44. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Country (2017-2028)
Figure 45. Germany Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. France Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. United Kingdom Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Russia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Italy Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Type (2017-2028)
Figure 51. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Application (2017-2028)
Figure 52. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Region (2017-2028)
Figure 53. China Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. South Korea Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. India Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Australia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. South America Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Type (2017-2028)
Figure 60. South America Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Application (2017-2028)
Figure 61. South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Country (2017-2028)
Figure 62. Brazil Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Argentina Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Type (2017-2028)
Figure 65. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Sales Market Share by Application (2017-2028)
Figure 66. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Country (2017-2028)
Figure 67. Turkey Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. UAE Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
